Elon Musk's Neuralink receives FDA approval for human trials of brain implant
Elon Musk's brain implant company, Neuralink, has received approval from the US Food and Drug Administration (FDA) to conduct its first human clinical study. The company has not yet announced when the trials will begin or what they will involve. Neuralink's brain implant aims to help people with neurological conditions such as paralysis, blindness, autism, depression, and schizophrenia. The FDA approval is a significant milestone for the company, which has faced several hurdles in gaining consent. US lawmakers have also urged regulators to investigate the company's animal testing practices.